Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

被引:1037
作者
Kochenderfer, James N. [1 ,2 ]
Wilson, Wyndham H. [3 ]
Janik, John E. [3 ]
Dudley, Mark E. [2 ]
Stetler-Stevenson, Maryalice [4 ]
Feldman, Steven A. [2 ]
Maric, Irina [1 ]
Raffeld, Mark [4 ]
Nathan, Debbie-Ann N. [2 ]
Lanier, Brock J. [2 ]
Morgan, Richard A. [2 ]
Rosenberg, Steven A. [2 ]
机构
[1] NIH, Dept Lab Med, Ctr Clin, Bethesda, MD 20892 USA
[2] NCI, Surg Branch, Bethesda, MD 20892 USA
[3] NCI, Metab Branch, Bethesda, MD 20892 USA
[4] NCI, Pathol Lab, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
CHIMERIC ANTIGEN RECEPTOR; HUMAN BONE-MARROW; IN-VIVO; ADOPTIVE IMMUNOTHERAPY; ANTITUMOR-ACTIVITY; LYMPHOCYTES; ANTIBODY; DIFFERENTIATION; PERSISTENCE; EFFICACY;
D O I
10.1182/blood-2010-04-281931
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Adoptive transfer of genetically modified T cells is an attractive approach for generating antitumor immune responses. We treated a patient with advanced follicular lymphoma by administering a preparative chemotherapy regimen followed by autologous T cells genetically engineered to express a chimeric antigen receptor (CAR) that recognized the B-cell antigen CD19. The patient's lymphoma underwent a dramatic regression, and B-cell precursors were selectively eliminated from the patient's bone marrow after infusion of anti-CD19-CAR-transduced T cells. Blood B cells were absent for at least 39 weeks after anti-CD19-CAR-transduced T-cell infusion despite prompt recovery of other blood cell counts. Consistent with eradication of B-lineage cells, serum immunoglobulins decreased to very low levels after treatment. The prolonged and selective elimination of B-lineage cells could not be attributed to the chemotherapy that the patient received and indicated antigen-specific eradication of B-lineage cells. Adoptive transfer of anti-CD19-CAR-expressing T cells is a promising new approach for treating B-cell malignancies. This study is registered at www.clinicaltrials.gov as #NCT00924326. (Blood.2010;116(20):4099-4102)
引用
收藏
页码:4099 / 4102
页数:4
相关论文
共 25 条
[1]   Development of human lymphoid cells [J].
Blom, Blanca ;
Spits, Hergen .
ANNUAL REVIEW OF IMMUNOLOGY, 2006, 24 :287-320
[2]   Treatment of Chronic Lymphocytic Leukemia With Genetically Targeted Autologous T Cells: Case Report of an Unforeseen Adverse Event in a Phase I Clinical Trial [J].
Brentjens, Renier ;
Yeh, Raymond ;
Bernal, Yvette ;
Riviere, Isabelle ;
Sadelain, Michel .
MOLECULAR THERAPY, 2010, 18 (04) :666-668
[3]   Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15 [J].
Brentjens, RJ ;
Latouche, JB ;
Santos, E ;
Marti, F ;
Gong, MC ;
Lyddane, C ;
King, PD ;
Larson, S ;
Weiss, M ;
Rivière, I ;
Sadelain, M .
NATURE MEDICINE, 2003, 9 (03) :279-286
[4]   A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening [J].
Chen, YT ;
Scanlan, MJ ;
Sahin, U ;
Tureci, O ;
Gure, AO ;
Tsang, SL ;
Williamson, B ;
Stockert, E ;
Pfreundschuh, M ;
Old, LJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (05) :1914-1918
[5]   SPECIFIC ACTIVATION AND TARGETING OF CYTOTOXIC LYMPHOCYTES THROUGH CHIMERIC SINGLE CHAINS CONSISTING OF ANTIBODY-BINDING DOMAINS AND THE GAMMA-SUBUNIT OR ZETA-SUBUNIT OF THE IMMUNOGLOBULIN AND T-CELL RECEPTORS [J].
ESHHAR, Z ;
WAKS, T ;
GROSS, G ;
SCHINDLER, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :720-724
[6]  
HARADA H, 1993, BLOOD, V81, P2658
[7]  
HWU P, 1995, CANCER RES, V55, P3369
[8]   THE CYTOPLASMIC DOMAIN OF THE T-CELL RECEPTOR ZETA-CHAIN IS SUFFICIENT TO COUPLE TO RECEPTOR-ASSOCIATED SIGNAL TRANSDUCTION PATHWAYS [J].
IRVING, BA ;
WEISS, A .
CELL, 1991, 64 (05) :891-901
[9]   Antitransgene Rejection Responses Contribute to Attenuated Persistence of Adoptively Transferred CD20/CDI9-Specific Chimeric Antigen Receptor Redirected T Cells in Humans [J].
Jensen, Michael C. ;
Popplewell, Leslie ;
Cooper, Laurence J. ;
DiGiusto, David ;
Kalos, Michael ;
Ostberg, Julie R. ;
Forman, Stephen J. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (09) :1245-1256
[10]   Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen [J].
Johnson, Laura A. ;
Morgan, Richard A. ;
Dudley, Mark E. ;
Cassard, Lydie ;
Yang, James C. ;
Hughes, Marybeth S. ;
Kammula, Udai S. ;
Royal, Richard E. ;
Sherry, Richard M. ;
Wunderlich, John R. ;
Lee, Chyi-Chia R. ;
Restifo, Nicholas P. ;
Schwarz, Susan L. ;
Cogdill, Alexandria P. ;
Bishop, Rachel J. ;
Kim, Hung ;
Brewer, Carmen C. ;
Rudy, Susan F. ;
VanWaes, Carter ;
Davis, Jeremy L. ;
Mathur, Aarti ;
Ripley, Robert T. ;
Nathan, Debbie A. ;
Laurencot, Carolyn M. ;
Rosenberg, Steven A. .
BLOOD, 2009, 114 (03) :535-546